Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 3Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Retinoblastoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Topotecan × Clear all
NCT00109798 2017-09-19

Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

The Methodist Hospital Research Institute

Phase NA Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

NCT00980551 2017-03-03

RELRB1

Children's Hospital Medical Center, Cincinnati

Phase NA Withdrawn
Other solid neoplasm

Retinoblastoma

NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡